Home >  MD Brand Connect >  Revolutionizing...

Revolutionizing Healthcare: Dr. K Sivakumar Unveils the Power of Diax.AI in Modern Medicine

Written By :  Dr. Nandita Mohan
By :  Dr Sivakumar Krishnamoorthy
Published On 2024-11-11 07:00 GMT   |   Update On 2024-11-22 08:50 GMT
Advertisement

DiaX.AI, an impactful startup aims to deliver data driven approach - Personalized Care through cutting edge technology for People with Diabetes and comorbid conditions and Precision Medicine through EMR platform for the Practitioners of Diabetes. It is Connecting Technology, Medicine, Decision Support Systems, Guideline based Therapy in single platform.

Whether it's analyzing complex medical data, assisting with diagnosis, or predicting patient outcomes, DiaX.AI combines the latest in AI technology with healthcare expertise to transform the way we approach patient care.

Advertisement

In this video, we dive into the core features of DiaX.AI, how it works in real-world scenarios, and explore how it’s shaping the future of healthcare, one diagnosis at a time.

Speaking to Medical Dialogues team, Dr K Sivakumar, the founder of DiaX.AI and the Managing Director and Consultant Diabetologist at Karunya Sugalaya Diabetes care and Research Centre at Kumbakonam, Tamil Nadu candidly explains his motivation behind the entrepreneurial journey.

He talks about his inspiration behind the creation of the application, the core functionality of the app, how it helps in improving patient care , the biggest challenges faced in its development and lastly, the future updates added to make it more useful.

He furthermore, explains in detail how this app can be used and be beneficial for the medical community at large, making their prescription process much simpler for use.

Check out more details of the app by clicking on the following link-

https://www.diax.ai/index.html


Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Why Wellness Planning and Health Insurance are Both Crucial for Financial Security?

Alkem launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer

Managing Nasal Congestion in Allergic Rhinitis: Whats the Mechanism of Action of Allegra D ?

PCV20 Launch in India: A Single Dose, Science-Driven Approach for Pneumococcal Disease Control

Tirzepatide superior to Semaglutide- SURMOUNT-5 Trial Results

Sanofi Consumer Healthcare India Limited launches Allegra-D in India: Non-Drowsy Allergy Relief with Nasal Decongestion

First Hybrid Endoscopic-Microscopic ENT Skill Lab Inaugurated at Dr. D.Y. Patil Medical College, Hospital & Research Centre

Dr D Y Patil Medical College, Hospital & Research Centre, Pimpri, Pune Hosts Roots-VIII Conference, Setting New Benchmarks in Aesthetic and Procedural Dermatology Education